Incyte Financial Statements (INCY)

Incytesmart-lab.ru   2021 2022 2023 2024 2025   LTM ?
Report date 08.02.2022 07.02.2023 13.02.2024 10.02.2025 10.02.2026   28.04.2026
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 2 986 3 395 3 696 4 241 5 141   5 361
Operating Income, bln rub 637.5 599.6 651.8 80.1 1 343   1 450
EBITDA, bln rub ? 630.2 599.6 919.4 408.2 1 760   1 871
Net profit, bln rub ? 948.6 340.7 597.6 32.6 1 287   1 432
OCF, bln rub ? 749.5 969.9 496.5 335.3 1 413   1 517
CAPEX, bln rub ? 181.0 77.8 47.5 86.3 58.9   65.9
FCF, bln rub ? 568.5 892.1 449.0 249.1 1 355   1 451
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 2 161 2 542 2 729 3 783 3 426   3 507
Cost of production, bln rub 187.3 253.4 315.2 377.7 372.1   403.4
R&D, bln rub 1 458 1 586 1 628 2 607 2 050   2 129
Interest expenses, bln rub 1.91 2.67 2.55 2.28 2.43   2.34
Assets, bln rub 4 933 5 841 6 782 5 444 6 958   7 339
Net Assets, bln rub ? 3 770 4 370 5 190 3 448 5 167   5 552
Debt, bln rub 44.8 41.5 38.3 43.5 69.4   33.8
Cash, bln rub 2 348 3 239 3 656 2 158 3 581   4 016
Net debt, bln rub -2 303 -3 198 -3 618 -2 115 -3 511   -3 982
Ordinary share price, rub 73.4 80.3 62.8 69.1 98.8   97.2
Number of ordinary shares, mln 220.4 222.0 223.6 207.1 195.2   199.3
Market cap, bln rub 16 179 17 831 14 042 14 305 19 280   19 368
EV, bln rub ? 13 876 14 634 10 424 12 191 15 769   15 386
Book value, bln rub 3 464 4 085 4 911 3 178 4 917   5 309
EPS, rub ? 4.30 1.53 2.67 0.16 6.59   7.18
FCF/share, rub 2.58 4.02 2.01 1.20 6.94   7.28
BV/share, rub 15.7 18.4 22.0 15.3 25.2   26.6
EBITDA margin, % ? 21.1% 17.7% 24.9% 9.62% 34.2%   34.9%
Net margin, % ? 31.8% 10.0% 16.2% 0.77% 25.0%   26.7%
FCF yield, % ? 3.51% 5.00% 3.20% 1.74% 7.03%   7.49%
ROE, % ? 25.2% 7.80% 11.5% 0.95% 24.9%   25.8%
ROA, % ? 19.2% 5.83% 8.81% 0.60% 18.5%   19.5%
P/E ? 17.1 52.3 23.5 438.6 15.0   13.5
P/FCF 28.5 20.0 31.3 57.4 14.2   13.3
P/S ? 5.42 5.25 3.80 3.37 3.75   3.61
P/BV ? 4.67 4.36 2.86 4.50 3.92   3.65
EV/EBITDA ? 22.0 24.4 11.3 29.9 8.96   8.22
Debt/EBITDA -3.66 -5.33 -3.93 -5.18 -1.99   -2.13
R&D/CAPEX, % 805.6% 2 038% 3 428% 3 022% 3 483%   3 230%
CAPEX/Revenue, % 6.06% 2.29% 1.28% 2.03% 1.14%   1.23%
Incyte shareholders